Doxorubicin-loaded perfluoropentane nanodroplets enhance radiofrequency ablation efficacy by relieving tumor hypoxia

Key Points

• The research aims to improve tumor ablation efficacy by combining chemotherapy with hypoxia modulation using a nanoplatform.
• Developed doxorubicin-loaded perfluoropentane nanodroplets
• Evaluated the integration of chemotherapy and hypoxia modulation
• Investigated the effects on radiofrequency ablation outcomes
• Demonstrated enhanced efficacy of radiofrequency ablation treatments
• Provided evidence that hypoxia modulation can decrease tumor recurrence
• Indicated potential for significant improvement in treatment outcomes after tumor ablation